Affiliation:
1. Voronezh State Medical University named after N.N. Burdenko
Abstract
The urgency of Epstein-Barr virus infection is explained by wide circulation of Epstein-Barr virus among children and adults, its tropism to immunocompetent cells with lifelong persistence after primary infection and polymorphism of clinical manifestations from subclinical forms, infectious mononucleosis to formation of oncological, autoimmune hematological diseases.Persistence of Epstein - Barr virus Leads to suppression of cellular immunity, decreased production of interferons and nonspecific protection factors, which contributes to reactivation of persistent infection, most often without mononucleosis-like syndrome, and the appearance of atypical mononuclears in blood with the formation of lymphoproliferative, intoxication, astheno-vegetative syndrome, long-term subfebrile condition, which dictates the need for immunocorrective therapy. This article presents a clinical case describing and analyzing the course of a chronic Epstein-Barr virus infection in a preschool child (5 years 8 months) with a pre-morbid background. Episodes of reactivation of chronic persistent infection occurred under the mask of acute respiratory infection with lymphoproliferative syndrome, purulent tonsillitis, purulent adenoiditis. Therapy, including antibiotics, short-course antiviral agents, bacterial lysates, and physiotherapy, had a temporary and short-lived effect. meglumine acridonacetate. The described clinical case demonstrates the effectiveness of the inclusion of meglumine acridonacetate, which has antiviral, immunomodulatory and anti-inflammatory effects, in the complex treatment of Epstein-Barr virus infection, This allowed to obtain fairly rapid positive clinical dynamics of relieving intoxication and febrile and lymphoproliferative syndromes in the acute period, and subsequently - astheno-vegetative syndrome and achieve the transition of active chronic Epstein - Barr virus infection into a latent form.
Reference45 articles.
1. Simovanyan E.N., Denisenko V.B., Grigoryan A.V., Kim M.A., Bovtalo L.F., Belugina L.V. Epstein-Barr Virus Infection in Children: Improving the Diagnosis and Treatment Program. Detskiye infektsii = Children Infections. 2016;15(1):15-24. (In Russ.) https://doi.org/10.22627/2072-8107-2016-15-1-15-24.
2. Kokoreva S.P., Kuprina N.P., Kotlova V.B. Herpesvirus Infection of Preschoolers in Organized Children's Groups. Modern Technologies in the Diagnosis, Treatment and Prevention of Infectious Diseases in Children: A Collection of Scientific Papers. Moscow; 2008, pp. 101-104. (In Russ.).
3. Kotlova V.B., Kokoreva S.P., Makarova A.V. Clinical and Laboratory Features and Risk Factors of Perinatal Epstein-Barr Virus Infection. Rossiyskiy vest-nik perinatologii i pediatrii = Russian Bulletin of Perinatology and Pediatrics. 2014;59(1):57-61. (In Russ.) Available at: https://www.ped-perinatology.ru/jour/article/view/34.
4. Khmilevskaya SA., Zaitseva I.A., Zryachkin N.I., Berezhnova IA. Features State of Hemostasis and Immunopathological Reactions in Epstein-Barr Virus Infection in Children. Zhurnal infektologii = Journal of Infectology. 2015;7(2): 75-82. (In Russ.) https://doi.org/10.22625/2072-6732-2015-7-2-75-82.
5. Ponezheva Zh.B., Grishaeva A.A., Popova T.I. Clinical variants of Epstein -Barr Virus Infection. RMZh = RMJ. 2019;(10):36-41. (In Russ.) Available at: https://www.rmj.ru/articles/infektsionnye_bolezni/Klinicheskie_formy_virusnoy_infekcii_Epshteyna__Barr/.